As depicted in Fig. 7A, BMP2 alteration was associated with tumor metastasis status and metastatic tumor indicators in TCGA database and correlated with Prediction Analysis of Microarray 50 (PAM50)-based molecular subtype and tumor stage in the METABRIC database. The gene discussed is BMP2; the disease is metastatic neoplasm.